March 2, 2023
Peter A. McCullough, MD, MPH™, “Internist, cardiologist, epidemiologist, author, and public figure. Since the beginning of the COVID-19 Pandemic, he has been a leader in the medical response” writes on February 21, 2023 in his Substack article entitled, “Dissolution of Spike Protein by Nattokinase”.
Dr. McCullough states:
- The therapeutic goal for the vaccine injured is removal, reduction, dissolution, or decay of the pathogenic SARS-CoV-2 Spike Proteins.
- “The synthetic mRNA carried on lipid nanoparticles appears to be resistant to breakdown by human ribonucleases by design so the product would be long-lasting and produce the protein product of interest for a considerable time”.
- “Vaccine injury syndromes is believed to be driven by accumulation of Spike protein in cells, tissues, and organs”.
- “Nattokinase is an enzyme is produced by fermenting soybeans with bacteria Bacillus subtilis var. natto and has been available as an oral supplement. It degrades fibrinogen, factor VII, cytokines, and factor VIII and has been studied for its cardiovascular benefits”.
- “Out of all the available therapies I have used in my practice and among all the proposed detoxification agents, I believe Nattokinase and related peptides hold the greatest promise for patients at this time”.
